KMR Group

Activities: Media Pharmaceutical

Trending Articles

  1. Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222 Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
  2. Overcoming CMC challenges in cell and gene therapy: part I Certara’s Dr Hien Anh Bruno, Associate Director, Chemistry, Manufacturing and Controls (CMC), and Dr Deven Shah, CMC Lead, propose mitigation strategies to address the CMC...
  3. Resolving capping issues in tablet manufacturing Natoli explores the various causes of capping and the methods to prevent it
  4. Effective ways to optimise heat exchangers Heat exchangers are used within a wide range of process industries as a way to transfer heat between two fluid streams across a medium in an energy conservative way
  5. Transforming healthcare with patient centricity In this opinion article, John Kytariolos, Head of Clinical and Scientific Affairs at Adragos Pharma, discusses patient-centric dosage forms, their properties and the impact...

Upcoming event

Cleanroom Conference UK

22–23 May 2024 | Exhibition | Birmingham, UK See all

Related Content

Media

Best countries for oncology clinical research

KMR Group’s recently completed their Best Places For Clinical Research report series for 2016. The Best Places series continues to highlight the strengths and weaknesses of nearly 100 countries for over a dozen different therapy areas and diseases; this year’s analyses confirm existing Industry trends while highlighting some surprising new shifts.
Media

Longer trial durations for large molecule clinical trials

Results from KMR Group’s Annual Cycle Time Report
Media

Large molecules enjoy greater success rates than small

From early phase to approval, small molecules have a 5% chance of success compared with 13% for large
Subscribe now